JPS5643212A - Treating agent for lipemia* alcoholism* acute* subacute and chronic hepatitis* obesity and similar pathological symtoms - Google Patents

Treating agent for lipemia* alcoholism* acute* subacute and chronic hepatitis* obesity and similar pathological symtoms

Info

Publication number
JPS5643212A
JPS5643212A JP17397479A JP17397479A JPS5643212A JP S5643212 A JPS5643212 A JP S5643212A JP 17397479 A JP17397479 A JP 17397479A JP 17397479 A JP17397479 A JP 17397479A JP S5643212 A JPS5643212 A JP S5643212A
Authority
JP
Japan
Prior art keywords
symtoms
lipemia
alcoholism
subacute
obesity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP17397479A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0121132B2 (nl
Inventor
Gomarasuka Piero
De Maruki Jiobanni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lpb Istituto Farmaceutico SpA
Original Assignee
Lpb Istituto Farmaceutico SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lpb Istituto Farmaceutico SpA filed Critical Lpb Istituto Farmaceutico SpA
Publication of JPS5643212A publication Critical patent/JPS5643212A/ja
Publication of JPH0121132B2 publication Critical patent/JPH0121132B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP17397479A 1979-09-14 1979-12-27 Treating agent for lipemia* alcoholism* acute* subacute and chronic hepatitis* obesity and similar pathological symtoms Granted JPS5643212A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT25706/79A IT1123142B (it) 1979-09-14 1979-09-14 Uso di glicerilfosforil derivati nella terapia di dislipemie ed epatiti,e composizioni farmaceutiche relative

Publications (2)

Publication Number Publication Date
JPS5643212A true JPS5643212A (en) 1981-04-21
JPH0121132B2 JPH0121132B2 (nl) 1989-04-19

Family

ID=11217502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17397479A Granted JPS5643212A (en) 1979-09-14 1979-12-27 Treating agent for lipemia* alcoholism* acute* subacute and chronic hepatitis* obesity and similar pathological symtoms

Country Status (10)

Country Link
JP (1) JPS5643212A (nl)
AU (1) AU520245B2 (nl)
BE (1) BE881071A (nl)
CH (1) CH645543A5 (nl)
DE (1) DE3000139C2 (nl)
FR (1) FR2464715A1 (nl)
GB (1) GB2057872B (nl)
IT (1) IT1123142B (nl)
NL (1) NL179873C (nl)
ZA (1) ZA796882B (nl)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005112731A (ja) * 2003-10-03 2005-04-28 Fancl Corp 肝機能改善剤
JP2014051459A (ja) * 2012-09-07 2014-03-20 Nof Corp 脂質代謝促進剤

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199972B (it) * 1985-05-08 1989-01-05 Lpb Ist Farm Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
JPH0751588B2 (ja) * 1985-07-03 1995-06-05 ハフスルント・ニコメド・フアルマ・アクチエンゲゼルシヤフト グリセロ―３（２）―ホスホ―ｌ―セリン誘導体又はその塩及びこれを含有する薬学的調製物
IT1213034B (it) * 1986-02-12 1989-12-07 Istituto Chemioterapico Di Lod Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
IT1212137B (it) * 1987-04-08 1989-11-08 Rosanna Lodi Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
EP0329053A1 (en) * 1988-02-15 1989-08-23 MAGIS FARMACEUTICI S.p.A. Choline esters of glycerophosphoric acids
EP0348859A1 (en) * 1988-07-01 1990-01-03 MAGIS FARMACEUTICI S.p.A. 1,2-di-O-acyl glycero(DI)phosphate of L-carnitine and its derivatives, a process for their preparation and pharmaceutical formulations which contain them
IT1230140B (it) * 1989-05-03 1991-10-14 Fidia Spa Derivati della serina, loro processo di preparazione e impiego in terapia umana
CN102138892B (zh) * 2010-02-03 2014-07-30 广州汉光医药进出口有限公司 甘磷酸胆碱注射制剂及其配制方法和检测方法
CN116966191A (zh) * 2022-04-22 2023-10-31 深圳先进技术研究院 甘油磷酸胆碱在调控细胞nad+水平和分布中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54117034A (en) * 1978-02-28 1979-09-11 Nippon Shoji Kk Treating agent for consciousness and perception motion disorder

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005112731A (ja) * 2003-10-03 2005-04-28 Fancl Corp 肝機能改善剤
JP2014051459A (ja) * 2012-09-07 2014-03-20 Nof Corp 脂質代謝促進剤

Also Published As

Publication number Publication date
AU5379279A (en) 1981-04-02
JPH0121132B2 (nl) 1989-04-19
NL179873C (nl) 1986-12-01
ZA796882B (en) 1980-11-26
DE3000139A1 (de) 1981-04-02
NL8000140A (nl) 1981-03-17
IT7925706A0 (it) 1979-09-14
GB2057872B (en) 1984-01-11
AU520245B2 (en) 1982-01-21
GB2057872A (en) 1981-04-08
BE881071A (fr) 1980-05-02
CH645543A5 (it) 1984-10-15
FR2464715A1 (fr) 1981-03-20
NL179873B (nl) 1986-07-01
FR2464715B1 (nl) 1983-07-22
DE3000139C2 (de) 1986-05-22
IT1123142B (it) 1986-04-30

Similar Documents

Publication Publication Date Title
GB8322753D0 (en) Immunometric and inhibition assays
JPS57151347A (en) Reinforcing material for reinforcing board material
DE3069186D1 (en) Reinforcement board
JPS5521292A (en) Thermal hardening resin pipe
JPS56151075A (en) Fin for surf board and its manufacture
YU205680A (en) Process for improving the corrosion resistance of nitrogenhardened components made of iron materials
JPS57151345A (en) Reinforcing material for reinforcing board material
JPS55145181A (en) Corrosion controlling agent
ZA791508B (en) Sludge drying system with sand recycle
JPS5643212A (en) Treating agent for lipemia* alcoholism* acute* subacute and chronic hepatitis* obesity and similar pathological symtoms
EP0127831A3 (en) Closed loop register control
ZA846284B (en) Iron with electronic control means
ZA807193B (en) Iron selective resins
GB8330744D0 (en) Treating cast iron member
GB2082480B (en) Treating barite ores
GB2115007B (en) Trivalent chromium electroplating process
GB8515282D0 (en) Cast iron
GB2152723B (en) Electronic cash registers
JPS55121210A (en) Nonncombustible inorganic coating material for electronic part
JPS5642643A (en) Reinforcing resin pipe
JPS57154703A (en) Electromagnetic wave absorber
JPS57170741A (en) Reinforcing material for reinforcing board material
JPS57193349A (en) Reinforcing material for reinforcing board material
JPS55130881A (en) Enhancement of side of inorganic board
JPS57131405A (en) Dryer for use with iron